Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akorn India Private Limited (AIPL), a wholly owned subsidiary of Akorn, has completed and closed the acquisition of certain assets of Kilitch Drugs India Limited (KDIL).
Subscribe to our email newsletter
KDIL is a contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma.
Akorn is a pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.
Akorn CEO Raj Rai said the company looks forward to working closely with the Promoters of KDIL to provide a smooth transition in the coming months.